person · Reporting owner

Fraser John D

Disclosed activity across 1 company

Tapewire entity: 43282
SEC CIK: 0001769195

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Aspira Women's Health Inc.AWHL · Entity 7871	Director	September 17, 2025	May 29, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aspira Women's Health Inc.

Report date September 17, 2025 · Filed May 29, 2026 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	566,393	Reported balance After 2025-09-17 transaction · row 1 Amendment: may correct only part of an earlier disclosure. 1 source row Row 1 · 2025-09-17 · Purchase · Acquired 16,389 · Balance 566,393
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2030-09-17	Direct	12,292	Reported balance After 2025-09-17 transaction · row 3 Amendment: may correct only part of an earlier disclosure. 1 source row Row 3 · 2025-09-17 · Purchase · Acquired 12,292 · Balance 12,292 F1: This report is being filed to correct the number of shares indirectly held by Mr. Fraser on September 17, 2025 and the presentation of the warrants held on September 17, 2025.
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.25 · Expires 2027-07-09	Direct	68,627	Reported balance Holding disclosure · report date 2025-09-17 · row 4 Amendment: may correct only part of an earlier disclosure. 1 source row Row 4 · Balance 68,627
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.35 · Expires 2031-03-05	Direct	900,633	Reported balance Holding disclosure · report date 2025-09-17 · row 5 Amendment: may correct only part of an earlier disclosure. 1 source row Row 5 · Balance 900,633
Common StockSEC Table I · non-derivative	IndirectBy Seamark Capital	287,769	Reported balance Holding disclosure · report date 2025-09-17 · row 2 Amendment: may correct only part of an earlier disclosure. 1 source row Row 2 · Balance 287,769 F1: This report is being filed to correct the number of shares indirectly held by Mr. Fraser on September 17, 2025 and the presentation of the warrants held on September 17, 2025.

Filing footnotes · ownership attribution and instrument terms

F1: This report is being filed to correct the number of shares indirectly held by Mr. Fraser on September 17, 2025 and the presentation of the warrants held on September 17, 2025.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 02, 2025 Filed Dec 4, 2025 13:33 UTC	Aspira Women's Health Inc. AWHL · Entity 7871	GrantStock Option (Right to Buy) · Derivative	314,811	$0.00 Strike: $0.35	$0.00	Disclosure SEC source: 0001493152-25-026110 · ownership.xml · derivative · entry 1 Fraser John D · CIK 0001769195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,811 Underlying: Common Stock · 314,811 shares Expires 2035-12-02 Read SEC document
September 17, 2025 Filed Sep 19, 2025 20:05 UTC	Aspira Women's Health Inc. AWHL · Entity 7871	PurchaseWarrant (Right to Buy) · Derivative	12,292	$0.00 Strike: $0.75	$0.00	Disclosure SEC source: 0001493152-25-014233 · ownership.xml · derivative · entry 3 Fraser John D · CIK 0001769195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 981,549 Underlying: Common Stock, par value $0.001 · 12,292 shares Expires 2030-09-17 Read SEC document
September 17, 2025 Filed Sep 19, 2025 20:05 UTC	Aspira Women's Health Inc. AWHL · Entity 7871	PurchaseCommon Stock	16,389	$0.45	$7,375.05	Disclosure SEC source: 0001493152-25-014233 · ownership.xml · nonDerivative · entry 1 Fraser John D · CIK 0001769195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 566,393 Read SEC document
September 17, 2025 Filed May 29, 2026 20:05 UTC Amendment	Aspira Women's Health Inc. AWHL · Entity 7871	PurchaseWarrant (Right to Buy) · Derivative	12,292	$0.00 Strike: $0.75	$0.00	Disclosure SEC source: 0001493152-26-026346 · ownership.xml · derivative · entry 3 Fraser John D · CIK 0001769195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,292 Underlying: Common Stock, par value $0.001 · 12,292 shares Expires 2030-09-17 F1 · balance_after: This report is being filed to correct the number of shares indirectly held by Mr. Fraser on September 17, 2025 and the presentation of the warrants held on September 17, 2025. Read SEC document
September 17, 2025 Filed May 29, 2026 20:05 UTC Amendment	Aspira Women's Health Inc. AWHL · Entity 7871	PurchaseCommon Stock	16,389	$0.45	$7,375.05	Disclosure SEC source: 0001493152-26-026346 · ownership.xml · nonDerivative · entry 1 Fraser John D · CIK 0001769195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 566,393 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.